Echoes of the type of thinking surrounding the delay in Novartis ratifying the ARDS deal they had signed:
that was because...
1. they wanted to renegotiate a higher price
2. they wanted to license congestive heart failure treatment
3. they wanted to buy Mesoblast
Echoes of the type of thinking surrounding the delay in Novartis...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.030(1.91%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.56 | $1.52 | $1.005M | 654.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 196 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 14465 | 3 |
View Market Depth
| Last trade - 10.36am 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |